Corey Carter
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Otorhinolaryngology top 10%
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Bryan Oronsky (16 shared papers)Tony Reid (8 shared papers)Arnold L. Oronsky (8 shared papers)Neil Oronsky (7 shared papers)Michelle Lybeck (7 shared papers)Susan J. Knox (2 shared papers)Pedro Cabrales (6 shared papers)Scott Caroen (7 shared papers)
- Journals
- Journal of Thoracic Oncology (4 papers)Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)Expert Opinion on Drug Delivery (1 paper)Blood (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Corey Carter
25 papers receiving 448 citations
Peers
Comparison fields: 5 of 79
- Oncology 136
- Otorhinolaryngology 21
- Pulmonary and Respiratory Medicine 129
- Cancer Research 56
- Immunology 69
Countries citing papers authored by Corey Carter
This map shows the geographic impact of Corey Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corey Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corey Carter more than expected).
Fields of papers citing papers by Corey Carter
This network shows the impact of papers produced by Corey Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corey Carter. The network helps show where Corey Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Corey Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 79 | |
| 2 | 2023 | 75 | |
| 3 | 2020 | 68 | |
| 4 | 2015 | 33 | |
| 5 | 2010 | 32 | |
| 6 | 2024 | 29 | |
| 7 | 2023 | 24 | |
| 8 | RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells. | 2016 | 23 |
| 9 | 2015 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2019 | 11 | |
| 12 | 2016 | 10 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 5 | |
| 15 | 2016 | 5 | |
| 16 | 2017 | 5 | |
| 17 | 2018 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2017 | 3 | |
| 20 | 2016 | 3 |
About Corey Carter
Corey Carter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Immunology, having authored 26 papers that have together received 456 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer Genomics and Diagnostics (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Immune cells in cancer (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (136 citations), Otorhinolaryngology (21 citations), Pulmonary and Respiratory Medicine (129 citations), Cancer Research (56 citations) and Immunology (69 citations). Corey Carter has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Bryan Oronsky, Tony Reid, Arnold L. Oronsky, Neil Oronsky, Michelle Lybeck, Susan J. Knox, Pedro Cabrales, Scott Caroen, Giuseppe Giaccone and Ronan J. Kelly. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Cancer Research, Expert Opinion on Drug Delivery and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.